Financials
- Market Capitalization 69.55 M
- Employee 20
- Founded 2008
- CEO N/A
- Website www.ibioinc.com
- Headquarter Delaware, United States
- FIGI BBG000D5F2L9
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4075 | CSBR Champions Oncology, Inc. - Common Stock | 5.36 USD | +1.71% | -12.13% | -10.22% | -19.03% | 74.47 M USD | ||
| 4095 | GANX Gain Therapeutics, Inc. - Common Stock | 1.68 USD | -4.55% | -6.15% | -15.58% | +13.51% | 71.66 M USD | ||
| 4116 | SPRO Spero Therapeutics, Inc. - Common Stock | 1.17 USD | -2.50% | -4.10% | -47.53% | -45.58% | 67.74 M USD | ||
| 4117 | XBIT XBiotech Inc. - Common Stock | 2.23 USD | -0.45% | -1.76% | -3.46% | -25.17% | 67.99 M USD |
Frequently asked questions about iBio, Inc. - Common Stock
What is the iBio, Inc. - Common Stock stock price today?
The current price of iBio, Inc. - Common Stock (IBIO) is 1.4. Over the past 24 hours, the stock has changed by +0.72%. Follow the IBIO chart for real-time price dynamics.
What is the stock ticker of iBio, Inc. - Common Stock?
iBio, Inc. - Common Stock trades under the ticker IBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is iBio, Inc. - Common Stock stock going up?
IBIO has changed by -2.78% over the last week, -20.00% over the last month, and -39.13% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of iBio, Inc. - Common Stock?
iBio, Inc. - Common Stock currently has a market capitalization of 69.55 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were iBio, Inc. - Common Stock earnings last quarter?
Last quarter, iBio, Inc. - Common Stock reported earnings of -0.06 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was iBio, Inc. - Common Stock revenue for the last quarter?
iBio, Inc. - Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was iBio, Inc. - Common Stock net income for the last quarter?
iBio, Inc. - Common Stock reported net income of -7.73 M for the last quarter. The previous quarter showed -8.99 M, which means net income changed by +14.04%.
How many employees does iBio, Inc. - Common Stock have?
As of the latest available data, iBio, Inc. - Common Stock has 20 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy iBio, Inc. - Common Stock stock?
You can buy iBio, Inc. - Common Stock (IBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in iBio, Inc. - Common Stock stock?
Investing in iBio, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IBIO chart and related analysis on metatrader.com as part of your research.